Precision Targeting
Cross-source consensus on Precision Targeting from 1 sources and 4 claims.
1 sources · 4 claims
How it works
Risks & contraindications
Highlighted claims
- CAAR T cells use self-antigen display to kill autoreactive B cells while preserving the rest of the B-cell repertoire. — Resetting autoimmune disease with CAR cell therapies
- Pan-B-cell depletion also removes protective humoral immunity, motivating more selective approaches. — Resetting autoimmune disease with CAR cell therapies
- IGHV4-34-targeted CAR T cells were developed to selectively eliminate lupus-associated B-cell clones while sparing normal B cells. — Resetting autoimmune disease with CAR cell therapies
- T-cell-driven diseases may be treated by selectively depleting pathogenic T-cell clones. — Resetting autoimmune disease with CAR cell therapies